LogicBio Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2018 to Q3 2022

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
LogicBio Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2018 to Q3 2022.
  • LogicBio Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2022 was 33M shares, a 0.02% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 33M +5.94K +0.02% Nov 8, 2022 10-Q 2022-11-14
Q2 2022 33M +722K +2.24% Aug 9, 2022 10-Q 2022-08-15
Q1 2022 33M +937K +2.93% Feb 25, 2022 10-K 2022-03-04
Q3 2021 33M +1.17M +3.68% Nov 8, 2021 10-Q 2021-11-15
Q2 2021 32.2M +8.6M +36.4% Jul 30, 2021 10-Q 2021-08-09
Q1 2021 32M +8.73M +37.5% Mar 9, 2021 10-K/A 2021-11-05
Q3 2020 31.8M +8.86M +38.7% Nov 5, 2020 10-Q 2020-11-09
Q2 2020 23.6M +974K +4.3% Aug 6, 2020 10-Q 2020-08-10
Q1 2020 23.3M +951K +4.26% Mar 10, 2020 10-K 2020-03-16
Q3 2019 22.9M Nov 7, 2019 10-Q 2019-11-12
Q2 2019 22.7M Aug 8, 2019 10-Q 2019-08-13
Q1 2019 22.3M Mar 31, 2019 10-K 2019-04-01
Q4 2018 22.2M Nov 30, 2018 10-Q 2018-12-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.